- $1.42bn
- $6.79bn
- CNY9.96bn
- 53
- 84
- 26
- 54
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 6-K |
Standards: | USG | USG | USG | USG | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,122 | 5,739 | 7,819 | 9,326 | 9,957 |
Cost of Revenue | |||||
Gross Profit | 1,043 | 1,550 | 1,779 | 1,936 | 1,922 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3,643 | 5,011 | 7,242 | 8,569 | 12,415 |
Operating Profit | 480 | 728 | 577 | 757 | -2,459 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -426 | -548 | -949 | -990 | -4,300 |
Provision for Income Taxes | |||||
Net Income After Taxes | -442 | -669 | -1,191 | -1,266 | -4,285 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -442 | -666 | -1,187 | -1,269 | -4,290 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -500 | -738 | -1,314 | -1,510 | -4,344 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.454 | -0.617 | -0.907 | -1.12 | -1.62 |